Venook AP - Search Results

1

A phase II study of bevacizumab plus erlotinib for gemcitabine-refractory metastatic pancreatic cancer.

Ko AH, Venook AP, Bergsland EK, Kelley RK, Korn WM, Dito E, Schillinger B, Scott J, Hwang J, Tempero MA. Ko AH, et al. Among authors: venook ap. Cancer Chemother Pharmacol. 2010 Nov;66(6):1051-7. doi: 10.1007/s00280-010-1257-5. Epub 2010 Feb 4. Cancer Chemother Pharmacol. 2010. PMID: 20130876 Clinical Trial.

2

Alternating hepatic intra-arterial floxuridine and fluorouracil: a less toxic regimen for treatment of liver metastases from colorectal cancer.

Stagg RJ, Venook AP, Chase JL, Lewis BJ, Warren RS, Roh M, Mulvihill SJ, Grobman BJ, Rayner AA, Hohn DC. Stagg RJ, et al. Among authors: venook ap. J Natl Cancer Inst. 1991 Mar 20;83(6):423-8. doi: 10.1093/jnci/83.6.423. J Natl Cancer Inst. 1991. PMID: 1825674 Clinical Trial.

3

Gallium-avid thymic hyperplasia in an adult after chemotherapy for Hodgkin disease.

Small EJ, Venook AP, Damon LE. Small EJ, et al. Among authors: venook ap. Cancer. 1993 Aug 1;72(3):905-8. doi: 10.1002/1097-0142(19930801)72:3<905::aid-cncr2820720340>3.0.co;2-2. Cancer. 1993. PMID: 8334644 Review.

4

A phase II study of constant-infusion floxuridine for the treatment of metastatic renal cell carcinoma.

Wilkinson MJ, Frye JW, Small EJ, Venook AP, Carroll PR, Ernest ML, Stagg RJ. Wilkinson MJ, et al. Among authors: venook ap. Cancer. 1993 Jun 1;71(11):3601-4. doi: 10.1002/1097-0142(19930601)71:11<3601::aid-cncr2820711122>3.0.co;2-#. Cancer. 1993. PMID: 8490909 Clinical Trial.

5

Hepatocellular carcinoma.

Bergsland EK, Venook AP. Bergsland EK, et al. Among authors: venook ap. Curr Opin Oncol. 2000 Jul;12(4):357-61. doi: 10.1097/00001622-200007000-00013. Curr Opin Oncol. 2000. PMID: 10888422 Review.

6

Phase I and pharmacokinetic trial of gemcitabine in patients with hepatic or renal dysfunction: Cancer and Leukemia Group B 9565.

Venook AP, Egorin MJ, Rosner GL, Hollis D, Mani S, Hawkins M, Byrd J, Hohl R, Budman D, Meropol NJ, Ratain MJ. Venook AP, et al. J Clin Oncol. 2000 Jul;18(14):2780-7. doi: 10.1200/JCO.2000.18.14.2780. J Clin Oncol. 2000. PMID: 10894879 Clinical Trial.

7

Shedding old paradigms: developing viruses to treat cancer.

Bergsland EK, Venook AP. Bergsland EK, et al. Among authors: venook ap. J Clin Oncol. 2002 May 1;20(9):2220-2. doi: 10.1200/JCO.2002.20.9.2220. J Clin Oncol. 2002. PMID: 11980991 No abstract available.

8

Key research issues in the management of hepatocellular carcinoma.

Venook AP. Venook AP. Cancer Chemother Pharmacol. 2004 Sep;54 Suppl 1:S87-90. doi: 10.1007/s00280-004-0893-z. Cancer Chemother Pharmacol. 2004. PMID: 15309518

9

Fractional genomic alteration detected by array-based comparative genomic hybridization independently predicts survival after hepatic resection for metastatic colorectal cancer.

Mehta KR, Nakao K, Zuraek MB, Ruan DT, Bergsland EK, Venook AP, Moore DH, Tokuyasu TA, Jain AN, Warren RS, Terdiman JP, Waldman FM. Mehta KR, et al. Among authors: venook ap. Clin Cancer Res. 2005 Mar 1;11(5):1791-7. doi: 10.1158/1078-0432.CCR-04-1418. Clin Cancer Res. 2005. PMID: 15756001

10

Critical evaluation of current treatments in metastatic colorectal cancer.

Venook A. Venook A. Oncologist. 2005 Apr;10(4):250-61. doi: 10.1634/theoncologist.10-4-250. Oncologist. 2005. PMID: 15821245 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

335 results

Search Page

Filters